Apogem Capital’s Encompass Health EHC Stock Holding History

Apogem Capital’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-3,699	Closed	-$209K	–	170
2022 Q1	$209K	Sell	3,699 -7,865	-68%	-$411K	0.14%	150
2021 Q4	$600K	Buy	+11,564	New	+$597K	0.39%	84
2021 Q3	–	Sell	-8,413	Closed	-$522K	–	191
2021 Q2	$522K	Sell	8,413 -1,307	-13%	-$87.1K	0.33%	102
2021 Q1	$633K	Buy	9,720 +868	+10%	+$56.6K	0.43%	75
2020 Q4	$582K	Buy	+8,852	New	+$521K	0.39%	85

Other funds holding EHC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.42B AUM 22.93% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Apogem Capital's EHC Position: Q2 2022 in Review

Apogem Capital sold out of Encompass Health (EHC) in Q2 2022, closing a stake of 3,699 shares — an estimated $209K sold.

Apogem Capital first reported a position in EHC in Q4 2020 and held it in 5 quarters. The position peaked at $633K in Q1 2021. 394 funds tracked by Wall St. Rank hold EHC as of Q2 2022.

Apogem Capital reported no remaining Encompass Health position as of Q2 2022 after selling out during the quarter.
Apogem Capital sold 3,699 Encompass Health shares in Q2 2022, an estimated $209K.
Apogem Capital first reported a position in Encompass Health in Q4 2020 and held it in 5 quarters.
Apogem Capital's Encompass Health position peaked at $633K in Q1 2021.
394 funds tracked by Wall St. Rank held Encompass Health as of Q2 2022.

Based on Apogem Capital's 13F filing for Q2 2022, filed 15 Aug 2022.